News
As bad as the inflation picture has been in the U.S., across the pond the experience has been far worse. In May, the United...
Hi, what are you looking for?
iFintechWorld
iFintechWorld
News
This article was written by Follow Alberto holds a Master’s degree in Business Economics. During his academic career he acquired an extensive managerial and...
News
This article was written by Follow As a tech-focused industry Research Analyst, I aim to provide differentiated insights, whether it is for investing, trading,...
News
This article was written by Follow Full time trader and investor. Instead of lengthy and boring articles, I prefer writing concise arguments about value...
News
A long-neglected factor to consider when choosing a residence is becoming more and more important to those who relocate in retirement. Because many people...
News
Potential has a shelf life.”― Margaret Atwood. Today, we take a look at a small developmental biotech concern that has had somewhat of a...
News
For the past century, educational institutions have used legacy admissions to give preference to family members of alumni or donors, especially their children. Data...
News
Millions of Americans are awaiting a Supreme Court ruling on President Joe Biden’s student loan forgiveness plan. The Supreme Court released several major decisions...
News
Strategy Launched by State Street Global Advisors, Inc. and managed by SSGA Funds Management, Inc., SPDR S&P Semiconductor ETF (NYSEARCA:XSD) invests in stocks of...
News
The numbers: Mortgage rates inched up, but they’re not likely to impact home-buying demand significantly as buyers have adjusted to the new normal of...
News
23 Stocks That Pass Legendary Former Wall Street Investment Manager Peter Lynch’s Screening Strategy
In this article I present the strategy used by the fund manager Peter Lynch. His approach capitalizes on the distinct advantage individual investors have...
News
The CBOE Volatility Index has been in a downtrend after spiking at the onset of the pandemic; a trend that has accelerated since at...
News
Pharma stocks performed well compared to the S&P 500 (SP500) during the final few months of 2022. Relative returns of the sometimes-defensive niche of...
